news – Page 160

Vitamin D3 as a Potential Therapeutic Agent in Polycystic Ovary Syndrome: Insights from a Prospective Double-Blind Randomized Trial

By MedXY 09/16/2025

A recent double-blind randomized controlled trial demonstrates that weekly supplementation with vitamin D3 significantly improves ovarian morphology, menstrual regularity, and ovulation rates in women with PCOS, suggesting a role as standalone or adjunctive therapy.

Clinical Updates news OB/GYN & Women's Health Specialties

Enhanced Therapeutic Outcomes in Overweight/Obese Women with PCOS: Combining Metformin and Semaglutide

By MedXY 09/16/2025

Combination therapy with metformin and semaglutide improves weight loss, metabolic parameters, menstrual function, and natural pregnancy rates in overweight/obese women with PCOS compared to metformin alone.

$Phase Ib Trial of Metformin Combined with Nivolumab in Refractory Solid Tumors: Safety, Dosage, and Preliminary Efficacy$

news Oncology Specialties

Phase Ib Trial of Metformin Combined with Nivolumab in Refractory Solid Tumors: Safety, Dosage, and Preliminary Efficacy

By MedXY 09/15/2025

A phase Ib study evaluated the safety, optimal dosing, pharmacokinetics, and preliminary efficacy of metformin with nivolumab in refractory solid tumors, showing good tolerability and promising responses in a subset of patients.

Clinical Updates news Oncology Specialties

Oral Metformin in Non-Muscle-Invasive Bladder Cancer: Insights from a Phase II Marker Lesion Study

By MedXY 09/15/2025

A phase II trial assessing oral metformin for low-grade non-muscle-invasive bladder cancer (NMIBC) found minimal antitumor activity and no significant mechanistic changes, challenging metformin’s role as an intravesical therapeutic agent in this context.

Allergy & Immunology Medical News news Oncology Specialties

Why Do Chimpanzees Rarely Get Cancer? Unveiling a Key Evolutionary Difference That Could Revolutionize Immunotherapy

By MedXY 09/14/2025

New research reveals that a protein called plasmin weakens human immune response against cancer compared to chimpanzees, offering promising strategies to enhance cancer immunotherapy.

Cardiology Critical Care Medical News news Specialties

Sudden Death Is Not So Sudden: Understanding, Preventing, and Responding to Cardiac Arrest

By MedXY 09/14/2025

Sudden death, often caused by heart conditions, is typically the culmination of gradual damage. This article explores warning signs, emergency response, and crucial prevention strategies to protect your heart and save lives.

Family Medicine & Nutrition Medical News news Specialties

The Ginger Miracle? Exploring the Anti-Aging Potential of Ginger and What the Science Really Says

By MedXY 09/14/2025

Recent studies suggest a compound in ginger may clear half of aging cells in two days, but practical benefits and safety concerns warrant cautious optimism. Here's a science-based look at ginger and aging.

Family Medicine & Nutrition Medical News news Specialties

Citrate: The New Molecular Key to Reversing Vascular Aging and Combating Cardiovascular Disease

By MedXY 09/14/2025

Recent research reveals that citrate, a natural compound found in citrus fruits, may significantly reverse vascular aging and reduce the risk of cardiovascular diseases by restoring mitochondrial function and vascular elasticity.

Neurology news Specialties

Enhanced Gait Rehabilitation in Chronic Stroke: Combining High-Intensity Interval Training with Robot-Assisted Gait Therapy

By MedXY 09/14/2025

A randomized controlled trial demonstrates that combining high-intensity interval training with robot-assisted gait therapy significantly improves gait speed, balance, and lower limb function in patients with chronic stroke compared to treadmill therapy alone.

AI Neurology news Specialties

Evaluating AI-Enhanced EMG Reporting: Insights from a Randomized Controlled Trial

By MedXY 09/14/2025

An RCT evaluated an AI-assisted framework for electrodiagnostic report interpretation, finding no significant improvement over standard physician reporting but highlighting potential workflow benefits for routine cases.

AI Clinical Updates news Psychiatry Specialties

Harnessing AI for Personalized Depression Treatment: Insights from the AID-ME Cluster Randomized Trial

By MedXY 09/14/2025

The AID-ME trial demonstrates that an AI-powered clinical decision support system significantly improves remission rates and accelerates symptom improvement in moderate to severe major depressive disorder.

Clinical Updates news Oncology Specialties

Unraveling the Complexity of Lung Cancer Screening: Comparative Insights from Two Landmark Trials

By MedXY 09/14/2025

Lung cancer screening reduces mortality but varies by risk factors, sex, and cancer histology. Analysis of NELSON and NLST trials highlights histology-driven heterogeneity and suggests broader screening criteria may improve outcomes.

Clinical Updates news

Enhancing Surgical History-Taking Skills in Medical Students Using AI-Driven Simulated Patients: A Randomized Controlled Trial

By MedXY 09/14/2025

This randomized trial shows that using a deep language learning model as a simulated patient significantly improves surgical history-taking skills and student confidence in senior medical students during clinical rotations.

AI Cardiology news Specialties

Harnessing AI: LLM-Based Conversational Agents Reduce Depression and Anxiety Among Young Adults in Short Video App Trial

By MedXY 09/14/2025

A 28-day RCT demonstrates that a conversational AI trained on a large language model effectively reduces mild depression and anxiety symptoms in young adults through dialog interventions integrated in short video apps.

Family Medicine & Nutrition news Specialties

Lower Your Blood Pressure by 8 mmHg in Just 10 Minutes a Day: The Power of Isometric Exercises

By MedXY 09/14/2025

Isometric exercises, a form of static muscle engagement, can lower blood pressure as effectively as some medications, offering a simple, drug-free way to protect your heart and vessels.

Medical News news

The Hidden Vascular Assassin: How Homocysteine Independently Accelerates Atherosclerosis

By MedXY 09/14/2025

Beyond cholesterol and blood pressure, homocysteine silently hardens arteries, driving cardiovascular disease progression independently—latest research reveals its biomechanical impact and prevention strategies.

Clinical Updates news

Evaluating Peer Coaching for Weight Management in Primary Care: Insights from a VA-Based Cluster Randomized Clinical Trial

By MedXY 09/13/2025

A cluster randomized trial in veterans assessed peer coaching for weight management, showing improved program attendance but no significant 12-month weight loss difference versus enhanced usual care.

Clinical Updates news Psychiatry Specialties

Personalized High-Definition Transcranial Direct Current Stimulation: A Promising Rapid Intervention for Moderate to Severe Depression

By MedXY 09/13/2025

A randomized clinical trial demonstrates that personalized high-definition transcranial direct current stimulation (HD-tDCS) significantly improves mood in patients with moderate to severe depression, showing faster and comparable effect sizes to conventional therapies and also reducing anxiety symptoms.

Cardiology General Surgery news Specialties

Unexpected Risks of Postoperative 20% Albumin Infusion in High-Risk Cardiac Surgery Patients: Insights from the ALBICS AKI Trial

By MedXY 09/13/2025

The ALBICS AKI trial reveals that postoperative infusion of 20% albumin increases acute kidney injury risk in high-risk cardiac surgery patients, challenging prior assumptions about albumin's nephroprotective role in this setting.

Clinical Updates news Oncology Radiology Specialties

Induction vs Adjuvant Chemoradiotherapy in High-Risk N2-N3 Nasopharyngeal Carcinoma: Insights from a Phase 3 Randomized Trial

By MedXY 09/12/2025

This phase 3 trial compares induction-concurrent chemotherapy with concurrent-adjuvant chemotherapy in high-risk N2 to N3 nasopharyngeal carcinoma, finding no significant difference in 3-year progression-free survival while highlighting distinct safety profiles.